| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031646570 |
| P356 | DOI | 10.2165/11530110-000000000-00000 |
| P698 | PubMed publication ID | 20369902 |
| P2093 | author name string | Timothy Corcoran Flynn | |
| P2860 | cites work | Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin | Q34615234 |
| Self-esteem and cosmetic enhancement | Q36077968 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 183-199 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | American Journal of Clinical Dermatology | Q18616212 |
| P1476 | title | Botulinum toxin: examining duration of effect in facial aesthetic applications | |
| P478 | volume | 11 |
| Q34771461 | A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses |
| Q40103460 | An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation |
| Q35592309 | Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines |
| Q38701424 | Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect |
| Q55260245 | Botulinum neurotoxin formulations: overcoming the confusion. |
| Q39541450 | Can botulinum toxin improve mood in depressed patients? |
| Q38564621 | Development and validation of a novel patient-reported treatment satisfaction measure for hyperfunctional facial lines: facial line satisfaction questionnaire |
| Q33631858 | Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials |
| Q35220461 | Duration of action of abobotulinumtoxina and onabotulinumtoxina: a randomized, double-blind study using a contralateral frontalis model |
| Q36807016 | Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study |
| Q44011948 | Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles |
| Q58749782 | Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior |
| Q38457792 | RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: an evaluator-blind, randomized, pilot study |
| Q43416402 | Skin Biomechanical Changes after Injection of Onabotulinum Toxin A: Prospective Assessment of Elasticity and Pliability |
| Q34419654 | Therapeutic use of botulinum toxin in migraine: mechanisms of action |
| Q33574491 | Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction |
| Q34242809 | Trends in the Use of Neurotoxins and Dermal Fillers by US Physicians |
Search more.